CD8 binding agents
US12364753B2 · kind B2 · utility
0Cited by
5References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 17, 2021 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Nov 19, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to agents that bind CD8 and their use as therapeutic and diagnostic agents. The present invention further relates to pharmaceutical compositions comprising the CD8 binding agents and their use in the treatment of various diseases, including, for example, cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.